Physician profile
Grant Webb
NPI 1144645177
$1,154.37
in general payments reported to CMS, 2019-2025
19 companies · $424 in 2025
The $424 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $92.92 · 2022: $79.66 · 2023: $227 · 2024: $330 · 2025: $424.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $982.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $981.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $197.57 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $178.98 | 2022-2025 | Farxiga, Breztri, Airsupra |
| Amgen INC. | $108.23 | 2022-2025 | Repatha, Otezla, Repatha |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $103.51 | 2025 | Caplyta |
| Glaxosmithkline, LLC. | $92.56 | 2022-2024 | Bexsero, Pediarix, Menveo |
| Shield Therapeutics INC | $66.30 | 2024 | |
| Phathom Pharmaceuticals, INC. | $60.98 | 2024-2025 | Voquezna |
| Novartis Pharmaceuticals Corporation | $56.84 | 2024 | |
| Lilly USA, LLC | $47.64 | 2023-2025 | Zepbound, Mounjaro, Jardiance |
| Merck Sharp & Dohme LLC | $43.08 | 2024 | Gardasil, Gardasil 9, Capvaxive |
| Otsuka America Pharmaceutical, INC. | $31.22 | 2021 | |
| Novo Nordisk INC | $30.67 | 2024-2025 | Ozempic, Rybelsus |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $29.25 | 2021-2024 | Trulance, Xifaxan |
| Pfizer INC. | $22.84 | 2025 | |
| Genentech USA, INC. | $21.02 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acadia Pharmaceuticals INC | $18.97 | 2025 | Daybue |
| Fisher & Paykel Healthcare INC | $16.91 | 2022 | |
| Mission Pharmacal Company | $15.55 | 2021 | |
| Acelrx Pharmaceuticals, INC. | $12.25 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grant Webb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.